Maven Securities »

Stoke Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 100k 13.50

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Call Call Option
United States Stl Corp Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Vaneck Etf Trust Put Put Option
United States Stl Corp Call Call Option
Select Sector Spdr Tr Put Put Option
Invesco Qqq Tr Put Put Option
Capri Holdings Call Call Option
Capri Holdings Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Ishares Tr Call Call Option
Select Sector Spdr Tr Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Call Call Option

View all positions for Maven Securities

Top funds holding Stoke Therapeutics

Skorpios Trust
BlackRock
Lynx1 Capital Management
Redmile Group
Baker Bros. Advisors
Rtw Investments
Morgan Stanley
Cowen And Company
Vanguard Group
State Street Corporation
Assenagon Asset Management
Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
Franklin Resources
Marshall Wace

View all funds holding Stoke Therapeutics